Showing results (111-120 of 271) with videos related to
Sort By:
Pageof 28
Pharmacology|January 1, 1976
Action of naloxone on the interferon-lowering activity of morphine in the mouseW F Geber, S S Lefkowitz, C Y HungJournal of Toxicology and Environmental Health|January 1, 1977
Duration of interferon inhibition following single and multiple injections of morphineW F Geber, S S Lefkowitz, C Y HungJournal of Toxicology and Environmental Health|January 1, 1986
Effects of NO2 on immune responsesS S Lefkowitz, J J McGrath, D L LefkowitzAnnals of Surgical Oncology|November 27, 1998
Interferon-mediated activation of the STAT signaling pathway in a human carcinoid tumorS Wang, S K Tyring, C M Townsend, et al.Biochemical and Biophysical Research Communications|April 28, 1997
Interferon regulates expression of mda-6/WAF1/CIP1 and cyclin-dependent kinases independently from p53 in B16 murine melanoma cellsI Arany, C M Fleischmann, S K Tyring, et al.Mutation Research|October 1, 1995
Chromosomal radiosensitivity of lymphocytes from skin cancer-prone patientsR el-Zein, P Shaw, S K Tyring, et al.Cancer|October 15, 1992
Human papillomavirus 16 exhibits a similar integration pattern in primary squamous cell carcinoma of the penis and in its metastasisF Scinicariello, P Rady, D Saltzstein, et al.Journal of the American Academy of Dermatology|May 1, 1992
Human papillomavirus type 11 in multiple squamous cell carcinomas in a patient with subacute cutaneous lupus erythematosusL M Cohen, S K Tyring, P Rády, et al.Archives of Dermatology|October 1, 1991
HLA and epidermolysis bullosa. Association between the HLA complex and recessive dystrophic epidermolysis bullosaS Vaidya, S K Tyring, L B Johnson, et al.Sexually Transmitted Diseases|August 26, 1998
A randomized phase II study comparing four different interferon therapies in patients with recalcitrant condylomata acuminataZ Trizna, T Evans, S Bruce, et al.Pageof 28